Drug Discovery

56 summarised stories about Drug Discovery, each linking back to the original source. Browse all topics →

+ Follow this topic

Key players

OpenAI Anthropic Co-Scientist Co-Scientist Google DeepMind Isomorphic Labs

Monday, 21 September 2026

Moderna's Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson's drug

Fortune 35

Cellular Intelligence added Moderna co-founder Bob Langer and AI researcher Yann LeCun to its scientific advisory board and Langer also joined as an observer on its board to guide AI-driven cell-behavior modeling for drug development. The company acquired global rights to STEM-PD, a Phase 2-ready Parkinson’s cell therapy with FDA Fast Track designation. As a result, Cellular Intelligence will continue advancing STEM-PD while plans to license its models for paid drug-discovery work and develop additional medicines using its AI foundation model and new biological data engine.

Read the full story

AI & Healthcare Foundation Models Drug Discovery

The daily briefing

Every AI story that matters,
in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.

TLDRocket 15 October 2026

Meta used today’s open-weight model drop to make a point: “frontier” doesn’t have to stay in the datacenter. Muse Spark Open ships as an 816B multimodal model with a 1 million–token context window, paired with Muse Code for coding and agent-style workflows—and it comes with strings. The license is free for use and fine-tuning, but it adds revenue-linked conditions (including advance notice above $20 million) and asks developers to display “Built with Muse Spark Open.” Running locally is a hardware project in itself: Meta says you need about 1TB of RAM. Still, the rollout is broad—Meta is making it available via multiple API platforms for desktop-focused tasks, and now through Amazon SageMaker JumpStart for deploy-to-your-own-AWS-account use, including BF16 and a 4-bit NVFP4 variant.

Read the full briefing →

Drug Discovery

Key players

Monday, 21 September 2026

Moderna's Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson's drug

Every AI story that matters, in your inbox by 8am.

Every AI story that matters,
in your inbox by 8am.